Dr Reddy’s Q2 Profit Falls 36% to Rs 913 Crore
Dr Reddy’s Laboratories reported a 36% year-on-year decline in net profit to Rs 913.4 crore for Q2 FY27. Revenue decreased marginally by 1.5%. The company's performance was pressured by weakness in North America but partially offset by growth in India and emerging markets, along with biosimilar approvals and strategic partnerships.
ET Markets·




